Noticias de ABT
Noticias del mercado
Últimas noticias sobre ABT — 275 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0
FDA Reports Baby Formula Safety, Highlights Abbott (ABT) Among C
Abbott Laboratories (ABT) Stock Price, Trades & News
La prueba se produce mientras Abbott Laboratories y otros fabricantes de fórmulas enfrentan un conjunto masivo de demandas por la supuesta presencia de contaminantes biológicos en fórmulas para bebés prematuros.
Ultreon 3.0 regulatory milestone sees Abbott Laboratories stock down 2.64% amid oversold conditions
Lawsuit Claims Abbott, Boston Scientific SCS Pre-Market Approval Supplements Caused Permanent Injuries
Fund Update: 1,400,797 ABBOTT LABORATORIES (ABT) shares added to FLOSSBACH VON STORCH SE portfolio
Abbott’s Ultreon 3.0 AI Imaging Clearance And What It Means For Valuation
Abbott’s FDA-Cleared Ultreon 3.0 Redefines Imaging in Coronary Interventions
Insider Buying: Abbott Laboratories (NYSE:ABT) Director Buys 10,000 Shares of Stock
Kevin Conroy (ABBOTT LABORATORIES: ABT) reports 131,451-share Form 3 holding
Abbott Laboratories director Daniel Starks buys $926,537 in shares By Investing.com
Página 4 de 14
